Model for PFS | Risk/baseline category | Beta | HR | 95% CI | p-value |
---|---|---|---|---|---|
Number of metastatic sites | 2/1 | 0.29 | 1.34 | 1.22-1.46 | <0.001 |
3 and more/1 | 0.53 | 1.70 | 1.50-1.94 | <0.001 | |
Presence of metastasis at diagnosis | M1/M0 | 0.12 | 1.13 | 1.03-1.23 | 0.008 |
Site of primary tumour | Rectum/Colon | 0.09 | 1.10 | 1.01-1.19 | 0.04 |
Age | 65-75 years/<65 years | −0.01 | 0.99 | 0.91-1.09 | 0.88 |
>75 years/<65 years | 0.01 | 1.01 | 0.81-1.25 | 0.96 | |
Model for OS | Risk/baseline category | Beta | HR | 95% CI | p-value |
Number of metastatic sites | 2/1 | 0.34 | 1.41 | 1.25-1.59 | <0.001 |
3 and more/1 | 0.66 | 1.94 | 1.65-2.27 | <0.001 | |
Presence of metastasis at diagnosis | M1/M0 | 0.23 | 1.25 | 1.12-1.41 | <0.001 |
Site of primary tumour | Rectum/Colon | 0.12 | 1.13 | 1.01-1.26 | 0.03 |
Age | 65-75 years/<65 years | −0.02 | 0.98 | 0.87-1.11 | 0.73 |
>75 years/<65 years | 0.17 | 1.18 | 0.89-1.56 | 0.24 |